Intellia Therapeutics Inc (NTLA)
Financing Cash Flow
$346.52M
TTM · Period ending: · USD
NTLA Financing Cash Flow
Latest reported$346.52Mperiod ending
Latest reported$346.52Mperiod ending
NTLA TTM Cash from Financing ($70.29M → $346.52M)
TTM financing cash flow
High-resolution chart · PNG
NTLA financing cash flow history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Financing Cash Flow (USD) |
|---|---|
| 346,519,000 | |
| 165,055,000 | |
| 131,486,000 | |
| 131,826,000 | |
| 99,161,000 | |
| 125,755,000 | |
| 185,747,000 | |
| 289,914,000 | |
| 226,824,000 | |
| 188,094,000 | |
| 130,323,000 | |
| 529,602,000 | |
| 534,477,000 | |
| 537,856,000 | |
| 582,955,000 | |
| 79,472,000 | |
| 724,175,000 | |
| 725,413,000 | |
| 736,688,000 | |
| 968,501,000 | |
| 300,418,000 | |
| 425,510,000 | |
| 371,779,000 | |
| 157,250,000 | |
| 203,053,000 | |
| 77,299,000 | |
| 76,434,000 | |
| 87,032,000 | |
| 42,812,000 | |
| 37,496,000 | |
| 40,217,000 | |
| 152,172,000 | |
| 150,363,000 | |
| 149,654,000 | |
| 142,981,000 | |
| 1,125,000 | |
| -1,100,000 | |
| 168,546,000 | |
| 167,304,000 | |
| 166,587,000 | |
| 235,157,000 | |
| 64,765,000 | |
| 70,288,000 | |
| 81,101,000 | |
| 14,485,000 |